Updates on Brain Tumors: Diagnosis and Treatment
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Clinical Neurology".
Deadline for manuscript submissions: 28 February 2025 | Viewed by 92
Special Issue Editors
Interests: neurology; neuro-oncology; brain tumors (primary and metastatic); neurologic complications of cancer and cancer therapies
Special Issue Information
Dear Colleagues,
In the last decade, there have been great advancements in the diagnosis and treatment of brain tumors, and the WHO classification has changed twice. Next-generation sequencing has revolutionized our understating of brain tumors, aiding in accurate diagnosis and opening up new avenues for targeted therapies. Multiple CNS-penetrating agents, including targeted therapies, as well as immunotherapy, have been FDA-approved for primary and metastatic brain tumors. An understanding of the molecular biology of tumors has provided experimental therapeutic insights. Innovative treatment approaches including oncolytic virus therapy and tumor vaccines, as well as the penetration of the BBB with implantable ultrasound devices, hold promise for future improvements in prognosis. This Special Issue will focus on the clinical advances in the diagnosis and management of primary and metastatic brain tumors that are driving modern neuro-oncological care.
We look forward to receiving your submissions for this Special Issue.
Dr. Jigisha P. Thakkar
Dr. Rimas V Lukas
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- primary brain tumors
- glioblastoma
- IDH mutant glioma
- meningioma
- brain metastases
- leptomeningeal disease
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
